SEOUL, South Korea, March 9, 2026 /PRNewswire/ -- Enhans, an enterprise Agentic AI company led by CEO Seung-hyun Lee, ...

Artificial intelligence is rapidly inventing new drugs for diseases from Parkinson's disease and antibiotic-resistant superbugs to rare lung conditions.

Stylus Medicine, a member of BioSpace’s NextGen Class of 2026, launched in May 2025 to develop new, less complex genetic medicines. The company’s in vivo approach has attracted “intense” interest from ...

Q4 2025 Earnings Call March 9, 2026 8:30 AM EDTCompany ParticipantsRoger James Hamilton - Founder, CEO & DirectorGaurav ...

As software takes on the driving role, Dor Shay of Element's Autofleet details how fleets must rethink incident response, compliance, and operational control to safely scale AV deployments.

The second day of B2BMX starts with a leader from one of the leading artificiual intelligence companies in the world: Dane Vahey, Head of B2B Marketing, OpenAI. After the timely keynote, immerse ...

Courtesy of Tianjin University. Multiple deputies to the 14th National People's Congress (NPC) and members of the 14th Na ...

Good morning. Welcome to this fireside chat with Insmed. I'm Joe Schwartz from the biopharma equity research team at Leerink Partners, and it's my great pleasure to be joined by Sara Bonstein, CFO.

The ascendant faction of the Republican Party is organizing to steal the 2028 Congressional and Presidential elections and cement minority rule over all three branches of the government of the United ...

This reason is enough to delay the Artemis II mission further, says a Mexican nuclear physicist to the Starlust team.

As the U.S. grapples with a housing affordability crisis, the single-minded focus of policymakers, practitioners and advocates alike is on boosting housing production to redress the radical mismatch ...

Summary: Workplace attrition threatens operational continuity and clinical trial timelines for life science professionals. The recent shift to remote and decentralized trials presents unique ...